These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 25910805)
1. Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor. Pires PW; Jackson WF; Dorrance AM Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H127-36. PubMed ID: 25910805 [TBL] [Abstract][Full Text] [Related]
2. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Rigsby CS; Pollock DM; Dorrance AM Microvasc Res; 2007 May; 73(3):198-205. PubMed ID: 17250855 [TBL] [Abstract][Full Text] [Related]
3. Effect of hypertension and carotid occlusion on brain parenchymal arteriole structure and reactivity. Sweet JG; Chan SL; Cipolla MJ J Appl Physiol (1985); 2015 Oct; 119(7):817-23. PubMed ID: 26294749 [TBL] [Abstract][Full Text] [Related]
4. Increased pressure-induced tone in rat parenchymal arterioles vs. middle cerebral arteries: role of ion channels and calcium sensitivity. Cipolla MJ; Sweet J; Chan SL; Tavares MJ; Gokina N; Brayden JE J Appl Physiol (1985); 2014 Jul; 117(1):53-9. PubMed ID: 24790017 [TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonism improves parenchymal arteriole dilation via a TRPV4-dependent mechanism and prevents cognitive dysfunction in hypertension. Diaz-Otero JM; Yen TC; Fisher C; Bota D; Jackson WF; Dorrance AM Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1304-H1315. PubMed ID: 30118343 [TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension. Chambers LC; Diaz-Otero JM; Fisher CL; Jackson WF; Dorrance AM J Hypertens; 2022 Sep; 40(9):1722-1734. PubMed ID: 35943101 [TBL] [Abstract][Full Text] [Related]
10. Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. Rigsby CS; Ergul A; Portik Dobos V; Pollock DM; Dorrance AM Am J Hypertens; 2011 Jun; 24(6):708-15. PubMed ID: 21350432 [TBL] [Abstract][Full Text] [Related]
11. Stroke development in stroke-prone spontaneously hypertensive rats alters the ability of cerebrovascular muscle to utilize internal Ca2+ to elicit constriction. Smeda JS Stroke; 2003 Jun; 34(6):1491-6. PubMed ID: 12750542 [TBL] [Abstract][Full Text] [Related]
12. Effect of hypertension and peroxynitrite decomposition with FeTMPyP on CBF and stroke outcome. Cipolla MJ; Sweet JG; Chan SL J Cereb Blood Flow Metab; 2017 Apr; 37(4):1276-1285. PubMed ID: 27317653 [TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats. Nakano M; Hirooka Y; Matsukawa R; Ito K; Sunagawa K Hypertens Res; 2013 Mar; 36(3):277-84. PubMed ID: 23096235 [TBL] [Abstract][Full Text] [Related]
14. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913 [TBL] [Abstract][Full Text] [Related]
15. Influence of graded changes in vasomotor tone on the carotid arterial mechanics in live spontaneously hypertensive rats. Lacolley P; Ghodsi N; Glazer E; Challande P; Brissac AM; Safar ME; Laurent S Br J Pharmacol; 1995 Aug; 115(7):1235-44. PubMed ID: 7582551 [TBL] [Abstract][Full Text] [Related]
16. [Time-course changes of myogenic tone of mesenteric small artery in spontaneously hypertensive rat]. Lin LJ; Tang FK; Hua N; Lu H; Di CX; Tang XZ; Li Y Sheng Li Xue Bao; 2012 Feb; 64(1):62-8. PubMed ID: 22348962 [TBL] [Abstract][Full Text] [Related]
17. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats. de las Heras N; Ruiz-Ortega M; Miana M; Rupérez M; Sanz-Rosa D; Aragoncillo P; Mezzano S; Cachofeiro V; Egido J; Lahera V J Hypertens; 2007 Mar; 25(3):629-38. PubMed ID: 17278980 [TBL] [Abstract][Full Text] [Related]
18. Effects of chronic nitric oxide synthase inhibition on cerebral arterioles in Wistar-Kyoto rats. Chillon JM; Baumbach GL J Hypertens; 2004 Mar; 22(3):529-34. PubMed ID: 15076158 [TBL] [Abstract][Full Text] [Related]
19. Treatment for cerebral small vessel disease: effect of relaxin on the function and structure of cerebral parenchymal arterioles during hypertension. Chan SL; Sweet JG; Cipolla MJ FASEB J; 2013 Oct; 27(10):3917-27. PubMed ID: 23783073 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature. Yamasaki E; Thakore P; Krishnan V; Earley S Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H461-H469. PubMed ID: 31886721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]